153 related articles for article (PubMed ID: 21875475)
41. The effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on platelet recovery in breast cancer patients undergoing autologous bone marrow transplantation.
Schuster MW; Beveridge R; Frei-Lahr D; Abboud CN; Cruickshank S; Macri M; Menchaca D; Holden J; Waller EK
Exp Hematol; 2002 Sep; 30(9):1044-50. PubMed ID: 12225796
[TBL] [Abstract][Full Text] [Related]
42. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
[TBL] [Abstract][Full Text] [Related]
43. [Effect of recombinant human thrombopoietin on endotoxin-induced thrombocytopenia in mice].
Jiang J; Wang B; Yu X; Xu H; Wang Y
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1108-1112. PubMed ID: 31657334
[TBL] [Abstract][Full Text] [Related]
44. Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy.
Yuan SM
Pak J Pharm Sci; 2015 Sep; 28(5):1793-6. PubMed ID: 26408899
[TBL] [Abstract][Full Text] [Related]
45. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
Iaffaioli RV; Tortoriello A; Facchini G; Caponigro F; Gentile M; Marzano N; Gravina A; Dimitri P; Costagliola G; Ferraro A; Ferrante G; De Marino V; Illiano A
J Clin Oncol; 1999 Mar; 17(3):921-6. PubMed ID: 10071285
[TBL] [Abstract][Full Text] [Related]
46. [An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].
Hatae M; Ariyoshi Y; Fukuoka M; Furuse K; Noda K; Hirabayashi K; Yakushiji M; Ogawa M; Takaku F
Gan To Kagaku Ryoho; 2005 Apr; 32(4):489-96. PubMed ID: 15853215
[TBL] [Abstract][Full Text] [Related]
47. [Clinical analysis of recombinant humanized thrombopoietin for treating 25 children with severe immune thrombocytopenia].
Zheng J; Ma JY; Su Y; Yang J; Zhang RD; Zhou X; Wu RH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):393-8. PubMed ID: 24763011
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy and safety of pemetrexed or gemcitabine combined with carboplatin as the first-line therapy in elderly patients with advanced non-small cell lung cancer].
Shi X; Yu XM; Zhang YP; Zhao J
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):221-4. PubMed ID: 23880005
[TBL] [Abstract][Full Text] [Related]
49. [Effectiveness and safety of rhIL-11 in the treatment of chemotherapy-induced thrombocytopenia].
Li L; Xu CG; Wang XW; Guo QS; Sun YH; Sun LM
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):377-9. PubMed ID: 16117904
[TBL] [Abstract][Full Text] [Related]
50. Recombinant human thrombopoietin therapy for primary immune thrombocytopenia in pregnancy: a retrospective comparative cohort study.
Lin J; Wang TF; Huang MJ; Huang HB; Chen PF; Zhou Y; Dai WC; Zhou L; Feng XS; Wang HL
BMC Pregnancy Childbirth; 2023 Nov; 23(1):820. PubMed ID: 38012579
[TBL] [Abstract][Full Text] [Related]
51. Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial.
Zatloukal P; Petruzelka L; Zemanová M; Kolek V; Skricková J; Pesek M; Fojtů H; Grygárková I; Sixtová D; Roubec J; Horenková E; Havel L; Průsa P; Nováková L; Skácel T; Kůta M
Lung Cancer; 2003 Sep; 41(3):321-31. PubMed ID: 12928123
[TBL] [Abstract][Full Text] [Related]
52. Gemcitabine and cisplatin treatment of advanced-stage non-small-cell lung cancer in patients given cisplatin on day 8.
Akcali Z; Calikusu Z; Sakalli H; Ozyilkan O
Tumori; 2008; 94(4):474-80. PubMed ID: 18822681
[TBL] [Abstract][Full Text] [Related]
53. Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer.
Shepherd FA; Cormier Y; Burkes R; Evans WK; Goss G; Klimo P; Feld R; Taylor M
Semin Oncol; 1997 Jun; 24(3 Suppl 8):S8-27-S8-30. PubMed ID: 9207313
[TBL] [Abstract][Full Text] [Related]
54. Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor.
Harker LA; Marzec UM; Kelly AB; Cheung E; Tomer A; Nichol JL; Hanson SR; Stead RB
Blood; 1997 Jan; 89(1):155-65. PubMed ID: 8978288
[TBL] [Abstract][Full Text] [Related]
55. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
Goldberg J
Curr Opin Mol Ther; 2000 Apr; 2(2):211-5. PubMed ID: 11249644
[TBL] [Abstract][Full Text] [Related]
56. Pharmacodynamic stimulation of thrombogenesis by angiotensin (1-7) in recurrent ovarian cancer patients receiving gemcitabine and platinum-based chemotherapy.
Pham H; Schwartz BM; Delmore JE; Reed E; Cruickshank S; Drummond L; Rodgers KE; Peterson KJ; diZerega GS
Cancer Chemother Pharmacol; 2013 Apr; 71(4):965-72. PubMed ID: 23370663
[TBL] [Abstract][Full Text] [Related]
57. A novel recombinant human thrombopoietin for treating prolonged isolated thrombocytopenia after allogeneic stem cell transplantation.
Sun YQ; Kong Y; Zhang XH; Wang Y; Shi MM; Song Y; Kong J; Fu HX; Yan CH; Xu LP; Liu KY; Huang XJ
Platelets; 2019; 30(8):994-1000. PubMed ID: 30569802
[TBL] [Abstract][Full Text] [Related]
58. Gemcitabine in brief versus prolonged low-dose infusion, both combined with carboplatin for advanced non-small cell lung cancer.
Beniwal SK; Patel KM; Shukla S; Parikh BJ; Shah S; Patel A
Indian J Cancer; 2012; 49(2):202-8. PubMed ID: 23107971
[TBL] [Abstract][Full Text] [Related]
59. Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma.
Danson S; Middleton MR; O'Byrne KJ; Clemons M; Ranson M; Hassan J; Anderson H; Burt PA; Fairve-Finn C; Stout R; Dowd I; Ashcroft L; Beresford C; Thatcher N
Cancer; 2003 Aug; 98(3):542-53. PubMed ID: 12879472
[TBL] [Abstract][Full Text] [Related]
60. A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer.
Kelly K; Mikhaeel-Kamel N; Pan Z; Murphy J; Prindiville S; Bunn PA
Clin Cancer Res; 2000 Sep; 6(9):3474-9. PubMed ID: 10999731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
